Regulation of adrenal function
Inhibition of steroidogenesis in rat adrenal cortex cells by a threonine analogue

https://doi.org/10.1016/0960-0760(91)90211-MGet rights and content

Abstract

We have investigated the ability of amino acid analogues of serine and threonine to inhibit the increase in steroidogenesis elicited by addition of ACTH or cAMP in cells isolated from the rat adrenal cortex. We have found that the serine analogues, D, L-isoserine, α-methyl-D, L-serine and L-homoserine, are almost totally ineffective in inhibiting this process but that the threonine analogue, D, L-β-hydroxynorvaline, at a concentration of 300 μ M inhibits stimulated steroid hormone biosynthesis by ca 95%, while inhibiting overall protein synthesis by only ca 40%. This inhibition was found to occur in a dose-dependent manner and to be reversible by a stoichiometric concentration of threonine. These studies suggest that β-hydroxynorvaline is functioning as a threonine analogue in our experimental system. Both the onset of inhibition by analogue and reversal of this inhibition by the natural amino acid occured rapidly, without detectable lag. Since results obtained using cAMP as stimulant parallel those obtained using ACTH, the inhibitory effect of the analogue seems to occur subsequent to the synthesis of cAMP. Additionally, the analogue does not inhibit the conversion of pregnenolone to corticosterone, suggesting the site of action of analogue occurs pior to the synthesis of pregnenolone from cholesterol. Thus, the analogue may be exerting its effect on a protein that is synthesized subsequent to ACTH addition and is important in the acute phase of stimulated steroid hormone biosynthesis. Further, since ACTH action on adrenal cortex cells causes the activation of protein kinase A, which phosphorylates serine and threonine residues, it is possible that the effect of the analogue is to prevent the phosphorylation of a newly-synthesized protein.

References (39)

Cited by (22)

  • Cantharidin and norcantharidin inhibit caprine luteal cell steroidogenesis in vitro

    2012, Experimental and Toxicologic Pathology
    Citation Excerpt :

    Both cantharidin and norcantharidin have potential clinical utility as inhibitors of protein phosphatase 1 and 2A (PP1, PP2A) (McCluskey et al., 2003). The possibility that phosphatases might influence secretory processes has also attracted attention recently, and phosphatase-linked mechanisms have been implicated extensively in several endocrine tissues, including islets of langerhans and chromaffin and pituitary cells (Gagliardino et al., 1991; Green and Orme-Johnson, 1991; Iriuchijima et al., 1992; Polettini et al., 1992; Abayasekara et al., 1996; Murphy and Jones, 1996; Ciereszko et al., 2001). Both cantharidin and norcantharidin have been used to assess the role of phosphatases in steroidogenesis (Abayasekara et al., 1996; Ciereszko et al., 2001).

  • Steroidogenic Acute Regulatory Protein

    1998, Vitamins and Hormones
View all citing articles on Scopus
View full text